Showing results (1-10 of 54) with videos related to
Sort By:
Pageof 6
Pharmaceuticals (Basel, Switzerland)|October 23, 2021
Implications of Antigen Selection on T Cell-Based ImmunotherapyFaye A Camp, Jill E SlanskySeminars in Immunology|March 25, 2020
Peptide mimotopes alter T cell function in cancer and autoimmunityJill E Slansky, Maki NakayamaOncoimmunology|June 5, 2013
Mimotope vaccine efficacy gets a "boost" from native tumor antigensJonathan D Buhrman, Jill E SlanskyImmunologic Research|September 1, 2012
Improving T cell responses to modified peptides in tumor vaccinesJonathan D Buhrman, Jill E SlanskyMolecular Carcinogenesis|May 10, 2020
T-cell receptor affinity in the age of cancer immunotherapyMichele M Hoffmann, Jill E SlanskyAnticancer Research|April 12, 2012
Multiple associations between a broad spectrum of autoimmune diseases, chronic inflammatory diseases and cancerAlexis L Franks, Jill E SlanskySeminars in Cancer Biology|July 27, 2007
Mobilizing the low-avidity T cell repertoire to kill tumorsRachel H McMahan, Jill E SlanskyInternational Journal of Molecular Sciences|February 15, 2022
Granzymes: The Molecular Executors of Immune-Mediated CytotoxicityZachary L Z Hay, Jill E SlanskyCancers|September 23, 2022
Antigens Expressed by Breast Cancer Cells Undergoing EMT Stimulate Cytotoxic CD8<sup>+</sup> T Cell ImmunityFaye A Camp, Tonya M Brunetti, Michelle M Williams, et al.Vaccines|September 23, 2015
Targeting Transcriptional Regulators of CD8+ T Cell Dysfunction to Boost Anti-Tumor ImmunityKatherine A Waugh, Sonia M Leach, Jill E SlanskyPageof 6